Cutaneous leishmaniasis: Toward the end of injectable therapy?;La leishmaniose cutanée en France: Vers la fin des traitements injectables?

Bulletin de la Societe de Pathologie Exotique

Volumn 96, Issue 5, 2004, Pages 383-388

  Buffet, P A ^a   Morizot, G ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Aminosidine sulfate; Amphotericine B; Cutaneous leishmaniasis; Fluconazole; Leishmaniasis; Meglumine antimonate; Miltefosine; Mucosal leishmaniasis; Paromomycine; Pentamidine; Pentavalent antimonial; Treatment

Indexed keywords

ANTILEISHMANIAL AGENT; FLUCONAZOLE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE;

DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG TOLERABILITY; EPIDEMIC; EVALUATION; EVOLUTION; HUMAN; LEISHMANIA; LEISHMANIA PANAMENSIS; LEISHMANIA SHAWI; REVIEW; RISK ASSESSMENT; SKIN LEISHMANIASIS; TREATMENT INDICATION; TREATMENT OUTCOME;

FRANCE; HUMANS; INJECTIONS; LEISHMANIASIS, CUTANEOUS;

EID: 1442314599     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. ALRAJHI AA, IBRAHIM EA, DE VOL EB, KHAIRAT M, FARIS RM & MAGUIRE JH - Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med, 2002, 346, 891-895.
2. ARANA BA, MENDOZA CE, RIZZO NR & KROEGER A - Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg, 2001, 65, 466-470.
3. ARANA BA, NAVIN TR, ARANA FE, BERMAN JD & ROSENKAIMER F - Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala. Clin Infect Dis, 1994, 18, 381-384.
4. ASILIAN A, JALAYER T, WHITWORTH JA, GHASEMI RL, NILFOROOSHZADEH M & OLLIARO P - A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg, 1995, 53, 648-651.
5. BEN SALAH A, ZAKRAOUI H, ZAATOUR A, FTAITI A, ZAAFOURI B et al.-A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am J Trop Med Hyg, 1995, 53, 162-166.
6. BERMAN JD - Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Rev Infect Dis, 1988, 10, 560-586.
7. BERMAN JD - Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis, 1997, 24, 684-703.
8. BRYCESON A - A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop Med Int Health, 2001, 6, 928-934.
9. BRYCESON A - Therapy in man. In: The leishmaniases. W.K. -K. Peters, R., Editor. 1987, Elsevier: London, p. 847-69.
10. BUFFET P, CAUMES E & GENTILINI M - Traitement des leishmanioses cutanées localisées. Ann Dermatol Vénéréol, 1994, 121, 503-511.
11. CAUMES E, CARRIERE J, GUERMONPREZ G, BRICAIRE F, DANIS M & GENTILINI M - Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis, 1995, 20, 542-548.
12. EL-ON J, HALEVY S, GRUNWALD MH & WEINRAUCH L -Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol, 1992, 27, 227-231.
13. EL-SAFI SH, MURPHY AG, BRYCESON AD & NEAL RA - A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Trans R Soc Trop Med Hyg, 1990, 84, 690-691.
14. FRANKE ED, LLANOS-CUENTAS A, ECHEVARRIA J, CRUZ ME, CAMPOS P et al.-Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis. Am J Trop Med Hyg, 1994, 51, 77-82.
15. FRANKE ED, WIGNALL FS, CRUZ ME, ROSALES E, TOVAR AA et al.- Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med, 1990, 113, 934-940.
16. GROGL M, SCHUSTER BG, ELLIS WY & BERMAN JD - Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. J Parasitol, 1999, 85, 354-359.
17. HARMS G, CHEHADE AK, DOUBAM, ROEPKE M, MOUAKEH A et al.-A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg, 1991, 85, 214-216.
18. HERWALDT BL, ARANA BA & NAVIN TR - The natural history of cutaneous leishmaniasis in Guatemala. J Infect Dis, 1992, 165, 518-527.
19. HERWALDT BL & BERMAN JD - Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg, 1992, 46, 296-306.
20. HERWALDT BL, STOKES SL & JURANEK DD - American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med, 1993, 118, 779-784.
21. JHA TK, OLLIARO P, THAKUR CP, KANYOK TP, SINGHANIA BL et al.-Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. Brit Med J, 1998, 316, 1200-1205.
22. JHA TK, SUNDAR S, THAKUR CP, BACHMANN P, KARBWANG J et al.-Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med, 1999, 341, 1795-1800.
23. KOFF AB & ROSEN T - Treatment of cutaneous leishmaniasis. J Am Acad Dermatol, 1994, 31, 693-708; quiz 708-710.
24. KRAUSE G & KROEGER A - Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg, 1994, 88, 92-94.
25. KRAUSE G & KROEGER A - Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study. Clin Infect Dis, 1999, 29, 466-467.
26. LANOTTE G, RIOUX JA & PRATLONG F - Ecologie des leishmanioses dans le Sud de la France. 14. Les leishmanioses en CÈvennes. Analyse clinique et biologique des formes viscérales et muqueuses.. Ann Parasitol Hum Comp, 1980, 55, 635-643.
27. LLANOS-CUENTAS A, ECHEVARRIA J, CRUZ M, LA ROSA A, CAMPOS P et al.-Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis. Clin Infect Dis, 1997, 25, 677-684.
28. MAGILL AJ - Epidemiology of the leishmaniases. Dermatol Clin, 1995, 13, 505-523.
29. MAGILL AJ, GROGL M, GASSER RA Jr, SUN W & OSTER CN -Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med, 1993, 328, 1383-1387.
30. MARSDEN PD - Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg, 1986, 80, 859-876.
31. MARSDEN PD - Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Tres Bracos, Bahia-Brazil. Rev Soc Bras Med Trop, 1994, 27, 93-101.
32. MARTINEZ S & MARR JJ - Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med, 1992, 326, 741-744.
33. MONTELIUS S, MAASHO K, PRATLONG F, LEBBAD M, GREGORY L & AKUFFO H - Skin rash for 15 years. Lancet, 1998, 352, 1438.
34. NAVIN TR, ARANA BA, ARANA FE, BERMAN JD & CHAJON JF - Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis, 1992, 165, 528-534.
35. PERRIN C, TAILAN B, DEL GIUDICE P, LEFICHOUX Y & MICHIELS JF - Dermonodular and visceral leishmaniasis due to Leishmania infantum with a new isoenzyme pattern. Clin Infect Dis, 1997, 24, 1283-1284.
36. SAENZ RE, DE RODRIGUEZ CG, JOHNSON CM & BERMAN JD -Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis. Am J Trop Med Hyg, 1991, 44, 394-398.
37. SOTO J, BUFFET P, GROGL M & BERMAN J - Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg, 1994, 50, 107-111.
38. SOTO J, HERNANDEZ N, MEJIA H, GROGL M & BERMAN J -Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate. Clin Infect Dis, 1995, 20, 47-51.
39. SOTO J, TOLEDO J, GUTIERREZ P, NICHOLLS RS, PADILLA J et al.-Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis, 2001, 33, E57-61.
40. SOTO JM, TOLEDO JT, GUTIERREZ P, ARBOLEDA M, NICHOLLS RS et al. -Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study. Am J Trop Med Hyg, 2002, 66, 147-151.
41. SOTO-MANCIPE J, GROGL M & BERMAN JD - Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis, 1993, 16, 417-425.
42. SUNDAR S, GUPTA LB, MAKHARIA MK, SINGH MK, VOSS A -Oral treatment of visceral leishmaniasis with miltefosine. Ann Trop Med Parasitol, 1999, 93, 589-597.
43. SUNDAR S, MAKHARIA A, MORE DK, AGRAWAL G, VOSS A et al.-Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis, 2000, 31, 1110-1113.
44. SUNDAR S, ROSENKAIMER F, MAKHARIA MK, GOYAL AK, MANDAL AK - Trial of oral miltefosine for visceral leishmaniasis. Lancet, 1998, 352, 1821-1823.
45. VELEZ I, AGUDELO S, HENDRICKX E, PUERTA J, GROGL M et al.-Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med, 1997, 126, 232-236.
46. WORTMANN G, MILLER RS, OSTER C, JACKSON J & ARONSON N - A randomized, double-blind study of the efficacy of a 10-or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis, 2002, 35, 261-267.
47. WORTMANN GW, FRASER SL, ARONSON NE, DAVIS C, MILLER RS et al.-Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis. Clin Infect Dis, 1998, 26, 1006-1007.